Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tolerance induction through early feeding to prevent food allergy in infants with eczema (TEFFA): rationale, study design, and methods of a randomized controlled trial.
Kalb B, Meixner L, Trendelenburg V, Unterleider N, Dobbertin-Welsch J, Heller S, Dölle-Bierke S, Roll S, Lau S, Lee YA, Fauchère F, Braun J, Babina M, Altrichter S, Birkner T, Worm M, Beyer K. Kalb B, et al. Among authors: altrichter s. Trials. 2022 Mar 12;23(1):210. doi: 10.1186/s13063-022-06126-x. Trials. 2022. PMID: 35279213 Free PMC article. Clinical Trial.
Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study.
Trendelenburg V, Dölle-Bierke S, Unterleider N, Alexiou A, Kalb B, Meixner L, Heller S, Lau S, Lee YA, Fauchère F, Braun J, Babina M, Altrichter S, Birkner T, Roll S, Dobbertin-Welsch J, Worm M, Beyer K. Trendelenburg V, et al. Among authors: altrichter s. Trials. 2022 Mar 28;23(1):236. doi: 10.1186/s13063-022-06149-4. Trials. 2022. PMID: 35346330 Free PMC article. Clinical Trial.
An interdisciplinary approach to characterize peanut-allergic patients-First data from the FOOD@ consortium.
Worm M, Alexiou A, Höfer V, Birkner T, Jeanrenaud ACSN, Fauchère F, Pazur K, Steinert C, Arnau-Soler A, Banerjee P, Diefenbach A, Dobbertin-Welsch J, Dölle-Bierke S, Francuzik W, Ghauri A, Heller S, Kalb B, Löber U, Marenholz I, Markó L, Scheffel J, Potapenko O, Roll S, Lau S, Lee YA, Braun J, Thiel A, Babina M, Altrichter S, Forslund SK, Beyer K. Worm M, et al. Among authors: altrichter s. Clin Transl Allergy. 2022 Oct 5;12(10):e12197. doi: 10.1002/clt2.12197. eCollection 2022 Oct. Clin Transl Allergy. 2022. PMID: 36225266 Free PMC article.
Current research and unmet needs in allergy and immunology in Germany: report presented by the DGfI and DGAKI task force Allergy & Immunology.
Albrecht M, Schaub B, Gilles S, Köhl J, Altrichter S, Voehringer D, Spillner E, Ehlers M, Jönsson F, Loser K, Mayer JU, Rösner LM, Möbs C, Heine G, Pfützner W. Albrecht M, et al. Among authors: altrichter s. Eur J Immunol. 2022 Jun;52(6):851-855. doi: 10.1002/eji.202270065. Eur J Immunol. 2022. PMID: 35654759 Free article. No abstract available.
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
Maurer M, Altrichter S, Bieber T, Biedermann T, Bräutigam M, Seyfried S, Brehler R, Grabbe J, Hunzelmann N, Jakob T, Jung A, Kleine-Tebbe J, Mempel M, Meurer M, Reich K, Ruëff F, Schäkel K, Sengupta K, Sieder C, Simon JC, Wedi B, Zuberbier T, Mahler V, Staubach P. Maurer M, et al. Among authors: altrichter s. J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2. J Allergy Clin Immunol. 2011. PMID: 21636116 Clinical Trial.
139 results